ASHTON GRAVES: Open Payments
NPI 1578300851 · CLINTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 42 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $471 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $164 |
| Novo Nordisk Inc | 9 | $139 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Exact Sciences Corporation | 6 | $95 |
| Amgen Inc. | 5 | $86 |
| Lilly USA, LLC | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
Products named: UBRELVY, FARXIGA, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, OTEZLA, Rybelsus, Kerendia.
Industry payments across MS — which companies pay providers there.
